Login
Evidence Feed
About
Diagnostics
New
Top genes
FAQ
Contact us
^
Login
Contact us
to learn more about
our Premium Content: News alerts, weekly reports and conference planners
DRUG CLASS:
Retinoic acid receptor agonist
DRUG CLASS:
Retinoic acid receptor agonist
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Related drugs:
‹
tretinoin (6)
tretinoin (2)
ST-001 nanoFenretinide (0)
tretinoin (6)
tretinoin (2)
ST-001 nanoFenretinide (0)
›
Associations
(8)
News
Trials
VERI cancer hierarchy
Reset Filters
MYB underexpression
Adenoid Cystic Carcinoma
MYB underexpression
Adenoid Cystic Carcinoma
tretinoin
Sensitive: C3 – Early Trials
tretinoin
Sensitive
:
C3
tretinoin
Sensitive: C3 – Early Trials
tretinoin
Sensitive
:
C3
NOTCH1 mutation
Adenoid Cystic Carcinoma
NOTCH1 mutation
Adenoid Cystic Carcinoma
tretinoin
Sensitive: C3 – Early Trials
tretinoin
Sensitive
:
C3
tretinoin
Sensitive: C3 – Early Trials
tretinoin
Sensitive
:
C3
WT1 overexpression
Myelodysplastic Syndrome
WT1 overexpression
Myelodysplastic Syndrome
cytarabine + decitabine + tretinoin
Sensitive: C3 – Early Trials
cytarabine + decitabine + tretinoin
Sensitive
:
C3
cytarabine + decitabine + tretinoin
Sensitive: C3 – Early Trials
cytarabine + decitabine + tretinoin
Sensitive
:
C3
TP53 mutation
Myelodysplastic Syndrome
TP53 mutation
Myelodysplastic Syndrome
cytarabine + decitabine + tretinoin
Sensitive: C3 – Early Trials
cytarabine + decitabine + tretinoin
Sensitive
:
C3
cytarabine + decitabine + tretinoin
Sensitive: C3 – Early Trials
cytarabine + decitabine + tretinoin
Sensitive
:
C3
ASXL1 mutation
Myelodysplastic Syndrome
ASXL1 mutation
Myelodysplastic Syndrome
cytarabine + decitabine + tretinoin
Sensitive: C3 – Early Trials
cytarabine + decitabine + tretinoin
Sensitive
:
C3
cytarabine + decitabine + tretinoin
Sensitive: C3 – Early Trials
cytarabine + decitabine + tretinoin
Sensitive
:
C3
PML-RARA fusion
Acute Promyelocytic Leukemia
PML-RARA fusion
Acute Promyelocytic Leukemia
tretinoin + arsenic trioxide
Sensitive: C3 – Early Trials
tretinoin + arsenic trioxide
Sensitive
:
C3
tretinoin + arsenic trioxide
Sensitive: C3 – Early Trials
tretinoin + arsenic trioxide
Sensitive
:
C3
PML-RARA fusion
Acute Promyelocytic Leukemia
PML-RARA fusion
Acute Promyelocytic Leukemia
cytarabine + idarubicin hydrochloride + tretinoin
Sensitive: C4 – Case Studies
cytarabine + idarubicin hydrochloride + tretinoin
Sensitive
:
C4
cytarabine + idarubicin hydrochloride + tretinoin
Sensitive: C4 – Case Studies
cytarabine + idarubicin hydrochloride + tretinoin
Sensitive
:
C4
PML-RARA fusion
Acute Myelogenous Leukemia
PML-RARA fusion
Acute Myelogenous Leukemia
tretinoin
Sensitive: C4 – Case Studies
tretinoin
Sensitive
:
C4
tretinoin
Sensitive: C4 – Case Studies
tretinoin
Sensitive
:
C4
^
^
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login